| Impact of bridging chemotherapy on clinical outcomes of CD19-specific CAR T cell therapy in children/young adults with relapsed/refractory B cell acute lymphoblastic leukemia S Shahid, K Ramaswamy, J Flynn, A Mauguen, K Perica, JH Park, ... Transplantation and cellular therapy 28 (2), 72. e1-72. e8, 2022 | 34 | 2022 |
| Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment S Shahid, SE Prockop Cancer Drug Resistance 4 (3), 646, 2021 | 15 | 2021 |
| Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN‐amplified neuroblastoma S Shahid, BH Kushner, S Modak, EM Basu, EM Rubin, G Gundem, ... Pediatric blood & cancer 68 (10), e29265, 2021 | 7 | 2021 |
| Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia S Shahid, N Ceglia, JB Le Luduec, A McPherson, B Spitzer, ... Blood Advances 7 (17), 5069-5081, 2023 | 4 | 2023 |
| Iatrogenic immunodeficiency-associated lymphoproliferative disorder in a child with B-cell acute lymphoblastic leukemia S Shahid, C Rossi, P Vyas, C Bollard, H Dave Pediatric Hematology and Oncology 36 (5), 309-316, 2019 | 3 | 2019 |
| Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies S Shahid, GC Flynn, A Mauguen, J Bieler, SE Prockop, A Scaradavou, ... Blood 142, 3476, 2023 | 2 | 2023 |
| Gene and Cellular Immunotherapy for Cancer A Ghobadi, JF DiPersio Humana Press, 2022 | 2 | 2022 |
| Developing a membrane-proximal CD33-targeting CAR T cell R Freeman, S Shahid, AG Khan, SC Mathew, S Souness, ER Burns, ... Journal for immunotherapy of cancer 12 (5), 2024 | 1 | 2024 |
| Bridging chemotherapy prior to CD19-specific CAR T cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia S Shahid, K Ramaswamy, J Flynn, A Mauguen, JJ Boelens, CJ Forlenza, ... 2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021 | 1 | 2021 |
| Gene Expression Changes and Signal Transduction Pathway Alterations in Primary Human Oral Epithelial Cells Exposed to Smokeless Tobacco Extracts R Rajapakse, A Basu, S Shahid, MP Timko American Journal of Plant Sciences 5 (24), 3558-3571, 2014 | 1 | 2014 |
| Engineered NKG2C+ NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndrome KB Lupo, MK Panjwani, S Shahid, R Sottile, C Lawry, G Kolk, ... bioRxiv, 2024.07. 16.603785, 2024 | | 2024 |
| Preclinical Evaluation of Chimeric Antigen Receptor-Modified Natural Killer Cells Targeting Membrane-Proximal CD33 in Acute Myelogenous Leukemia S Shahid, T Kontopoulos, W Cai, S Souness, S Yoo, S Monette, ... Transplantation and Cellular Therapy 30 (2), S176-S177, 2024 | | 2024 |
| A quality improvement initiative standardizing premedication for blood product transfusions S Shahid, J Rosenzweig, A Troullioud Lucas, SS McThenia, C Fong, ... Pediatric Blood & Cancer 71 (1), e30753, 2024 | | 2024 |
| A PROSPECTIVE QUALITY IMPROVEMENT INITIATIVE TO STANDARDIZE PREMEDICATION FOR BLOOD PRODUCT TRANSFUSIONS S Shahid, S Mcthenia, AT Lucas, J Rosenzweig, M Degliuomini, C Fong, ... PEDIATRIC BLOOD & CANCER 70, S428-S429, 2023 | | 2023 |
| Clinical Outcomes and Salvage Therapies of Pediatric Patients with Progressive B-ALL Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy A Bidgoli, GC Yametti, S Shahid, AC Harris, MI Cancio, B Spitzer, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
| Signatures of Immune Evasion in Pediatric Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation S Shahid, N Ceglia, JB Le Luduec, A McPherson, B Spitzer, V Bojilova, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
| Immune Escape after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia S Shahid, N Ceglia, L Luduec, A McPherson, B Spitzer, V Bojilova, ... Blood 140 (Supplement 1), 10209-10210, 2022 | | 2022 |
| CD19-specific car-t cells for the treatment of cns chloromas in children with relapsed/refractory b-cell acute lymphoblastic leukemia S Shahid, M Cancio, SS Haque, Y Khakoo, E McWilliams, ... BONE MARROW TRANSPLANTATION 57 (SUPPL 1), 137-138, 2022 | | 2022 |
| TO PREMEDICATE OR NOT? A LOOK AT PREMEDICATIONS FOR BLOOD PRODUCT TRANSFUSIONS AT MSK KIDS J Rosenzweig, AT Lucas, S Shahid, S Mcthenia, C Fong, M Degliuomini, ... PEDIATRIC BLOOD & CANCER 69, S376-S376, 2022 | | 2022 |
| TCRi: Information theoretic metrics for single cell RNA and TCR sequencing in cancer N Ceglia, ZM Sethna, Y Elhanati, B Burman, A Chow, D Zamarin, ... bioRxiv, 2022.10. 01.510457, 2022 | | 2022 |
